|
1
|
Morita Y, Tomida J and Kawamura Y:
Responses of Pseudomonas aeruginosa to antimicrobials. Front
Microbiol. 4:4222014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li XZ, Plésiat P and Nikaido H: The
challenge of efflux-mediated antibiotic resistance in Gram-negative
bacteria. Clin Microbiol Rev. 28:337–418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kiser TH, Obritsch MD, Jung R, MacLaren R
and Fish DN: Efflux pump contribution to multidrug resistance in
clinical isolates of Pseudomonas aeruginosa. Pharmacotherapy.
30:632–638. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Livermore DM: Of Pseudomonas, porins,
pumps and carbapenems. J Antimicrob Chemother. 47:247–250. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Okamoto K, Gotoh N and Nishino T:
Extrusion of penem antibiotics by multicomponent efflux systems
MexAB-OprM, MexCD-OprJ and MexXY-OprM of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 46:2696–2699. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xavier DE, Picão RC, Girardello R,
Fehlberg LC and Gales AC: Efflux pumps expression and its
association with porin down-regulation and beta-lactamase
production among Pseudomonas aeruginosa causing bloodstream
infections in Brazil. BMC Microbiol. 10:2172010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Khuntayaporn P, Montakantikul P,
Santanirand P, Kiratisin P and Chomnawang MT: Molecular
investigation of carbapenem resistance among multidrug-resistant
Pseudomonas aeruginosa isolated clinically in Thailand. Microbiol
Immunol. 57:170–178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
American Thoracic Society, ; Infectious
Diseases Society of America, . Guidelines for the management of
adults with hospital-acquired, ventilator-associated and
healthcare-associated pneumonia. Am J Respir Crit Care Med.
171:388–416. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo N, Zhao X, Li W, Shi C, Meng R, Liu Z
and Yu L: The synergy of berberine chloride and totarol against
Staphylococcus aureus grown in planktonic and biofilm cultures. J
Med Microbiol. 64:891–900. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dziedzic A, Wojtyczka RD and Kubina R:
Inhibition of oral Streptococci growth induced by the complementary
action of berberine chloride and antibacterial compounds.
Molecules. 20:13705–13724. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gokgoz N Budeyri, Avci FG, Yoneten KK,
Alaybeyoglu B, Ozkirimli E, Sayar NA, Kazan D and Akbulut B
Sariyar: Response of Escherichia coli to prolonged berberine
exposure. Microb Drug Resist. 23:531–544. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shao J, Shi G, Wang T, Wu D and Wang C:
Antiproliferation of berberine in combination with fluconazole from
the perspectives of reactive oxygen species, ergosterol and drug
efflux in a fluconazole-resistant Candida tropicalis isolate. Front
Microbiol. 7:15162016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li D, Xu Y, Zhang D, Quan H, Mylonakis E,
Hu D, Li M, Zhao L, Zhu L, Wang Y and Jiang YY: Fluconazole assists
berberine to kill fluconazole-resistant Candida albicans.
Antimicrob Agents Chemother. 57:6016–6027. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morita Y, Nakashima K, Nishino K, Kotani
K, Tomida J, Inoue M and Kawamura Y: Berberine is a novel type
efflux inhibitor which attenuates the MexXY-mediated aminoglycoside
resistance in Pseudomonas aeruginosa. Front Microbiol. 7:12232016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Clinical and Laboratory Standards
Institute (CLSI), . Methods for dilution antimicrobial
susceptibility tests for bacteria that grow aerobically; Approved
StandardCLSI Document M07-A10. 10th. CLSI; Wayne, PA, USA: 2015
|
|
16
|
Odds F: Synergy, antagonism and what the
chequerboard puts between them. J Antimicrob Chemother. 52:12003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jayaraman P, Sakharkar MK, Lim CS, Tang TH
and Sakharkar KR: Activity and interactions of antibiotic and
phytochemical combinations against Pseudomonas aeruginosa in vitro.
Int J Biol Sci. 6:556–568. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Yao X, Zhu Z, Tang T, Dai K,
Sadovskaya I, Flahaut S and Jabbouri S: Effect of berberine on
Staphylococcus epidermidis biofilm formation. Int J Antimicrob
Agents. 34:60–66. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poole K and Srikumar R: Multidrug efflux
in Pseudomonas aeruginosa: Components, mechanisms and clinical
significance. Curr Top Med Chem. 1:59–71. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sobel ML, Hocquet D, Cao L, Plesiat P and
Poole K: Mutations in PA3574 (nalD) lead to increased MexAB-OprM
expression and multidrug resistance in laboratory and clinical
isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother.
49:1782–1786. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cao L, Srikumar R and Poole K: MexAB-OprM
hyperexpression in NalC-type multidrug-resistant Pseudomonas
aeruginosa: Identification and characterization of the nalC gene
encoding a repressor of PA3720-PA3719. Mol Microbiol. 53:1423–1436.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fonseca AP and Sousa JC: Effect of
antibiotic-induced morphological changes on surface properties,
motility and adhesion of nosocomial Pseudomonas aeruginosa strains
under different physiological states. J Appl Microbiol.
103:1828–1837. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
El Amin N, Giske CG, Jalal S, Keijser B,
Kronvall G and Wretlind B: Carbapenem resistance mechanisms in
Pseudomonas aeruginosa: Alterations of porin OprD and efflux
proteins do not fully explain resistance patterns observed in
clinical isolates. APMIS. 113:187–196. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stermitz FR, Lorenz P, Tawara JN, Zenewicz
LA and Lewis K: Synergy in a medicinal plant: Antimicrobial action
of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump
inhibitor. Proc Natl Acad Sci USA. 97:pp. 1433–1437. 2000;
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ettefagh KA, Burns JT, Junio HA, Kaatz GW
and Cech NB: Goldenseal (Hydrastis canadensis L.) Extracts
synergistically enhance the antibacterial activity of berberine via
efflux pump inhibition. Planta Med. 77:835–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ball AR, Casadei G, Samosorn S, Bremner
JB, Ausubel FM, Moy TI and Lewis K: Conjugating berberine to a
multidrug efflux pump inhibitor creates an effective antimicrobial.
ACS Chem Biol. 1:594–600. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Samosorn S, Tanwirat B, Muhamad N, Casadei
G, Tomkiewicz D, Lewis K, Suksamrarn A, Prammananan T, Gornall KC,
Beck JL and Bremner JB: Antibacterial activity of berberine-NorA
pump inhibitor hybrids with a methylene ether linking group. Bioorg
Med Chem. 17:3866–3872. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Severina II, Muntyan MS, Lewis K and
Skulachev VP: Transfer of cationic antibacterial agents berberine,
palmatine and benzalkonium through bimolecular planar phospholipid
film and Staphylococcus aureus membrane. IUBMB Life. 52:321–324.
2001. View Article : Google Scholar : PubMed/NCBI
|
